Akum Gets CDSCO Panel Nod to Manufacture, Market Glimepiride, Lobeglitazone FDC Dr. Divya Colin22 May 2023 6:00 PM ISTNew Delhi: The drug major Akum Pharmaceuticals has got the green signal from the Subject Expert Committee (SEC) functional under the Central Drug...
Synokem Pharma Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Dr. Divya Colin18 May 2023 6:00 PM ISTNew Delhi: Granting the Phase III clinical trial study waiver for the proposed antidiabetic fixed-dose combination (FDC), the Subject Expert Committee...
Sun Pharma Gets CDSCO panel nod to manufacture, market antidiabetic FDC drug Dr. Divya Colin24 Feb 2023 6:00 PM ISTNew Delhi: In a significant development, pharmaceutical major, Sun Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional...
Dr. Reddy proposal to market antidiabetic FDC of Imeglimin and Vildagliptin rejected by CDSCO Panel Dr. Divya Colin2 Nov 2022 6:00 PM ISTNew Delhi: Noting that the clinical experience with the drug Imeglimin is very limited, the Subject Expert Committee (SEC) functional under the...
Glenmark gets CDSCO Panel nod to manufacture,market Lobeglitazone, Metformin antidiabetic FDC Susmita Roy31 Oct 2022 6:00 PM ISTNew Delhi: Highlighting the clinical trial results that demonstrate the efficacy and safety of combination treatment of Lobeglitazone and Metformin in...
USV slashes price of diabetes drug Jalra DP by 20 percent Dr. Nandita Mohan10 Oct 2022 2:02 PM ISTIn a move to make diabetes therapy more accessible to patients, Indian pharma major USV has brought down the price of its product Jalra-DP,...
Submit complete CT Report :CDSCO Tells Glenmark on antidiabetic FDC drug Dr. Divya Colin23 Sept 2022 6:00 PM ISTNew Delhi: In response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate...
NovoNordisk gets CDSCO panel okay to study anti-diabetic drug Semaglutide Dr. Divya Colin5 April 2022 5:56 PM ISTNew Delhi: In line with the drug major Novo-Nordisk's justification for anti-diabetic drug Semaglutide the Subject Expert Committee (SEC) of the...
Health Bulletin 19/February/2022 Roshni Dhar19 Feb 2022 5:28 PM ISTHere are Top Health stories for the dayOnline courses to doctors even if mandated by Medical Council should be taxed under GST: AAR Delhi: Medical...
Serdia Pharma gets CDSCO nod for anti-diabetic FDC of extended-release Gliclazide 60mg plus Metformin 1000mg tablet Susmita Roy18 Feb 2022 1:34 PM ISTNew Delhi: In a significant development, Serdia® Pharmaceuticals (India) Pvt. Ltd. has got approval from the Central Drugs Standard Control...
Alkem gets CDSCO panel okay to manufacture, market Metformin, Sitagliptin FDC Medical Dialogues Team12 Nov 2021 6:18 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted permission to...
Glenmark gets CDSCO panel nod to study antidiabetic drug Lobeglitazone Sulfate Medical Dialogues Team6 Oct 2021 6:26 PM ISTNew Delhi: In a significant development, drug firm Glenmark has got a green signal from the Subject Expert Committee (SEC) functional under the...
